Diazyme Laboratories, Inc. HUMAN LAMBDA FREE LIGHT CHAIN ASSAY, KIT
The Diazyme HUMAN LAMBDA FREE LIGHT CHAIN ASSAY, KIT (DZ170A-DZL) is an in vitro diagnostic reagent kit designed for the quantitative determination of free lambda light chains in human serum using automated clinical chemistry analyzers. This assay utilizes immunoturbidimetric methodology, where specific antibodies react with free lambda light chains to form insoluble complexes, resulting in increased turbidity proportional to the concentration of free lambda light chains present in the sample. The kit is intended for use as an aid in the diagnosis and monitoring of diseases associated with abnormal production of immunoglobulin free light chains, such as multiple myeloma and related plasma cell disorders. The assay is calibrated against international standards and provides high sensitivity and specificity for clinical laboratory applications.